Our paper detailing the ASCB MAC name change is out ⬇️⬇️⬇️ Maximizing Access to Cell Biology for PEERS: Retracting the term minority in favor of a more inclusive lexicon | Molecular Biology of the Cell molbiolcell.org/doi/full/10.10…

It is with great excitement that we announce that the 5th Puerto Rico Cancer Research Meeting is supported by the NCI under the award R13CA294959 5th Puerto Rico Cancer Research Meeting October 4, 2024 Embassy Suites, San Juan, PR Sponsor [email protected]

“No longer acceptable to say a woman with a complaint in her 30’s CAN’T have breast cancer” Dr. Vonderheide The Breast Cancer Research Foundation on the rise of 17 cancers in younger patients. So important. We hear this issue from our young IBC pts all the time. #endcancer

Very alarming indeed!

Puerto Rico might be just 100 x 35 miles, but the talent and creativity among its people are boundless. An image that speaks volume—Puerto Ricans at #NDiSTEM SACNAS. 🇵🇷

#CellBio2024 kick start with Tina Termini Antentor Othrell Hinton, Jr PhD (A.J. Hinton) Starbird Lab Transition Academy Organizing your lab and budget was 🔥🔥🔥

So wonderful to re-connect with my friend and colleague Tina Termini while attending #CellBio2024

Finally, I met Dr. Arnaldo Díaz at the #CellBio2024 poster session! Hope to have more underrepresented scientists in meetings presenting their science!!! 🧬 🧫👩🏻‍🔬

This is #CellBio2024 former PhD students ⁦@gortiz105⁩ niw a #postdoc ⁦Baylor University⁩ and Ivette Suarez-Arroyo an Associate Professor ⁦UCC⁩ #MAC

Thrilled to share work from our MD Anderson Cancer Center IBC team & Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Dana-Farber’s Breast Oncology Center IBC team supported by IBC Research Fdn and Susan G. Komen to validate a new IBC scoring system to improve IBC diagnosis! #thinkibc academic.oup.com/jnci/advance-a…

Timescales in Cell Biology

Thanks ESMO - Eur. Oncology for including IBC in the #esmobreast2025 line up. Great brainstorming with this group and strong message: guideline concordant care for all IBC, use the Susan G. Komen IBC tools at diagnosis, don’t de-escalate off protocol! #bcsm #thinkibc

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

NIH is temporarily extending eligibility for some mentored career development awards. If your award prematurely ended on/after Jan. 1, 2025, you can apply for a new mentored career development award if all other requirements are met. grants.nih.gov/news-events/ni…

As we anxiously wait to receive clarification from NIH and new guidelines/limitations of animal research in preclinical drug development projects, I just want to remind everyone that..

We will be offering the 2nd Latino Cancer Patient Advocate Training in February 2026. Still looking for sponsors for this unique training. Let me know if you are interested in sponsoring. We can chat! Pic from the 1st training

Las voces científicas que tanta luz brindaron a los puertorriqueños durante la pandemia, no estan calladas, están cansadas. Aun así, la misma responsabilidad que sentimos en ese tiempo, sentimos hoy. Las vacunas salvan vidas.

Come join us 😃